Record Number of Bendamustine Abstracts Accepted for Presentation at the ... SYS-CON Media (press release) Two oral and three poster presentations focus on indolent NHL (iNHL) and MCL, comparing treatment with bendamustine-rituximab (B-R) to the standard first-line treatment, CHOP-R/CVP-R. One study demonstrated improved complete response rates and ... |
